homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

September 17, 2019

Can Purdue Pharma settlement win judge's approval?

By GEOFF MULVIHILL and STEVE LeBLANC
Associated Press

BOSTON — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity.

Whether the company can pull it off remains to be seen, especially with about half the states opposed to the deal.


 
. . .


To read this story in full login or purchase a subscription.




Email or user name:
Password:
 
Forgot password? Click here.